BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20964620)

  • 1. Activation of CYP3A-mediated testosterone 6β-hydroxylation by tanshinone IIA and midazolam 1-hydroxylation by cryptotanshinone in human liver microsomes.
    Qiu F; Zhang R; Wang G; Gao C; Sun J; Jiang J; Ma Y
    Xenobiotica; 2010 Dec; 40(12):800-6. PubMed ID: 20964620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA.
    Yu C; Ye S; Sun H; Liu Y; Gao L; Shen C; Chen S; Zeng S
    Chem Biol Interact; 2009 Jan; 177(1):58-64. PubMed ID: 18805405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of tanshinones on rat CYP3A2 and CYP2C11 activity and its structure-activity relationship.
    Wang X; Yeung JH
    Fitoterapia; 2011 Jun; 82(4):539-45. PubMed ID: 21262326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tanshinones from Salvia miltiorrhiza on CYP2C19 activity in human liver microsomes: enzyme kinetic and molecular docking studies.
    Hu T; Zhou X; Wang L; Or PM; Yeung JH; Kwan YW; Cho CH
    Chem Biol Interact; 2015 Mar; 230():1-8. PubMed ID: 25686904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interaction studies of tanshinones with tolbutamide, a model CYP2C11 probe substrate, using liver microsomes, primary hepatocytes and in vivo in the rat.
    Wang X; Lee WY; Or PM; Yeung JH
    Phytomedicine; 2010 Mar; 17(3-4):203-11. PubMed ID: 19679455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome p4501A2.
    Ueng YF; Kuo YH; Peng HC; Chen TL; Jan WC; Peter Guengerich F; Lin YL
    Xenobiotica; 2003 Jun; 33(6):603-13. PubMed ID: 12851037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences and substrate specificity of CYP3A heteroactivation by efavirenz.
    Kosugi Y; Takahashi J
    Xenobiotica; 2015 Apr; 45(4):345-52. PubMed ID: 25387130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate.
    Polasek TM; Miners JO
    Eur J Clin Pharmacol; 2006 Mar; 62(3):203-8. PubMed ID: 16416302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro.
    Wang X; Cheung CM; Lee WY; Or PM; Yeung JH
    Phytomedicine; 2010 Sep; 17(11):868-75. PubMed ID: 20638257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytochrome P-450 3A4: in vitro drug-drug interaction patterns are substrate-dependent.
    Wang RW; Newton DJ; Liu N; Atkins WM; Lu AY
    Drug Metab Dispos; 2000 Mar; 28(3):360-6. PubMed ID: 10681383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of warfarin hydroxylation by major tanshinones of Danshen (Salvia miltiorrhiza) in the rat in vitro and in vivo.
    Wu WW; Yeung JH
    Phytomedicine; 2010 Mar; 17(3-4):219-26. PubMed ID: 19577456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thin-layer chromatography analysis of human CYP3A-catalyzed testosterone 6beta-hydroxylation.
    Waxman DJ; Chang TK
    Methods Mol Biol; 2006; 320():133-41. PubMed ID: 16719384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth-inhibitory and apoptosis-inducing effects of tanshinones on hematological malignancy cells and their structure-activity relationship.
    Li H; Zhang Q; Chu T; Shi HY; Fu HM; Song XR; Meng WT; Mao SJ; Jia YQ
    Anticancer Drugs; 2012 Sep; 23(8):846-55. PubMed ID: 22495618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking and enzyme kinetic studies of dihydrotanshinone on metabolism of a model CYP2D6 probe substrate in human liver microsomes.
    Zhou X; Wang Y; Or PM; Wan DC; Kwan YW; Yeung JH
    Phytomedicine; 2012 May; 19(7):648-57. PubMed ID: 22541637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP3A5 Contributes significantly to CYP3A-mediated drug oxidations in liver microsomes from Japanese subjects.
    Yamaori S; Yamazaki H; Iwano S; Kiyotani K; Matsumura K; Honda G; Nakagawa K; Ishizaki T; Kamataki T
    Drug Metab Pharmacokinet; 2004 Apr; 19(2):120-9. PubMed ID: 15499178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Action of Panaxytriol on Midazolam 1'-Hydroxylation and 4-Hydroxylation Mediated by CYP3A in Liver Microsomes and Rat Primary Hepatocytes.
    He F; Zhang W; Zeng C; Xia C; Xiong Y; Zhang H; Huang S; Liu M
    Biol Pharm Bull; 2015; 38(10):1470-7. PubMed ID: 26424012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effects of hydrophilic organic solvents on CYP3A-mediated drug-drug interaction in vitro.
    Iwase M; Kurata N; Ehana R; Nishimura Y; Masamoto T; Yasuhara H
    Hum Exp Toxicol; 2006 Dec; 25(12):715-21. PubMed ID: 17286149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of classic and atypical neuroleptics on cytochrome P450 3A (CYP3A) in rat liver.
    Wójcikowski J; Haduch A; Daniel WA
    Pharmacol Rep; 2012; 64(6):1411-8. PubMed ID: 23406751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation.
    Lee WY; Chiu LC; Yeung JH
    Food Chem Toxicol; 2008 Jan; 46(1):328-38. PubMed ID: 17892911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited contribution of CYP3A5 to the hepatic 6beta-hydroxylation of testosterone.
    Kamdem LK; Meineke I; Koch I; Zanger UM; Brockmöller J; Wojnowski L
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):71-7. PubMed ID: 15232676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.